Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Jantlen A. Backer et al.
Summary: The SARS- CoV-2 Omicron variant has a growth advantage over the Delta variant due to higher transmissibility, immune evasion, or a shorter serial interval.
Letter
Medicine, General & Internal
Wanwisa Dejnirattisai et al.
Article
Multidisciplinary Sciences
Kenrie P. Y. Hui et al.
Summary: SARS-CoV-2 variants pose a threat to global public health. The Omicron variant replicates faster in bronchi but less efficiently in the lung parenchyma compared to other variants. All variants of concern have similar cellular tropism.
Article
Virology
Frederic Grabowski et al.
Summary: Omicron, a highly mutated variant of SARS-CoV-2, has rapidly spread and approached fixation in South Africa and has been detected worldwide. Its exponential growth and short doubling time may be attributed to its ability to evade immunity and infect both recovered and vaccinated individuals. The growth rate of Omicron compared to Delta is considerably higher, indicating a potential for larger epidemic outbreaks.
Article
Multidisciplinary Sciences
Matthew McCallum et al.
Summary: The SARS-CoV-2 Omicron variant evades antibody-mediated immunity and exhibits enhanced affinity for host cells due to accumulation of spike mutations and remodeling of interactions with the ACE2 receptor.
Article
Microbiology
Allison J. Greaney et al.
Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.
CELL HOST & MICROBE
(2021)
Editorial Material
Medicine, General & Internal
Salim S. Abdool Karim et al.
Article
Medicine, General & Internal
Thomas Ward et al.
Summary: This study analyzed the transmission patterns of new variants of SARS-CoV-2 in England from October 2020 to July 2021, taking into account different age groups, geographic locations, and ethnicities. The B.1.617.2 variant showed a clear transmission advantage over the B.1.1.7 variant, with exponential growth observed in all age groups. Early interventions were effective in reducing the growth of the B.1.617.2 variant in specific ethnic groups.
Editorial Material
Medicine, General & Internal
Aaron Richterman et al.
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Article
Biochemistry & Molecular Biology
Chang Liu et al.
Summary: Recent study examined the neutralizing ability of monoclonal antibodies, convalescent and vaccine sera against the Indian variants B.1.617.1 and B.1.617.2, showing that the neutralization of these variants is reduced compared to the ancestral strains, without widespread antibody escape as seen in other variants like B.1.351.
Article
Biology
Lorenzo Pellis et al.
Summary: Early assessments of COVID-19 growth rate were uncertain due to limited data, but as cases were recorded in multiple countries, more reliable inferences could be made. Physical distancing interventions typically did not show impact until at least 9 days after implementation, during which time confirmed cases could grow eightfold. Precise estimates of the time-sensitive basic reproduction number R-0 were found to be less critical than temporal patterns for initiating interventions.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
(2021)
Article
Biology
Adam J. Kucharski et al.
JOURNAL OF MATHEMATICAL BIOLOGY
(2016)
